The effect of CYP2C19 polymorphism on the pharmacokinetics and acid-inhibitory effects of oral lansoprazole and omeprazole
C. H. J. BEKKERS, D. J. TOUW, C. B. H. W. LAMERS, W. P. GEUSVolume:
54
Year:
2002
Language:
english
Pages:
1
DOI:
10.1046/j.1365-2125.2002.t01-7-01714.x
File:
PDF, 164 KB
english, 2002